Key result
Total myocardial scar score and LAD viability independently predict follow-up LVEF changes in ischemic cardiomyopathy.
Why the study?
This study was conducted to assess the relationship between myocardial scar burden, including extent and severity, and follow-up left ventricular ejection fraction.
Does myocardial scar burden and LAD viability predict improvement in LVEF in patients with ischemic cardiomyopathy?
Observational (n=178)
Single-blind
No
Does myocardial scar burden and LAD viability predict improvement in LVEF in patients with ischemic cardiomyopathy?
Myocardial scar burden and LAD territory viability assessed by CMR are independent predictors of LVEF improvement in patients with ischemic cardiomyopathy.
Background This study was conducted to assess the relationship between scar burden (extent and severity) and the follow-up left ventricular ejection fraction (LVEF). Methods Patients were referred for viability assessment with late gadolinium enhancement (LGE) on cardiovascular magnetic resonance imaging. To measure the transmural extent of LGE in each segment (scar score), we used a five-point scale system. Baseline ejection fraction (EF) and at follow-up were recorded. LVEF classified as non-severe and severely depressed. Results The study included 178 patients (males: 88.8%; mean age: 57.1±10.02 years; mean baseline LVEF: 28.61±10.39). In patients with severe baseline LVEF, the mean scar percentage was higher than that in patients who had non-severe LVEF (38.8±19.41 vs. 24.61±21.21; p˂0.001). On linear regression analysis, aldosterone antagonist and total scar score significantly predicted follow-up ejection fraction (EF) (B=-7.083, p˂0.001 and B=-3.038, p=0.038, respectively). Left anterior descending artery (LAD) territory viability and baseline EF significantly predicted change in EF in patients with LVEF ≤ 35% (B=5.389, p=0.009 and B=-0.581, p˂0.001, respectively). On binary regression analysis for the prediction of at least 5% improvement in EF in patients with baseline EF ≤ 35%, baseline EF and LAD viability were significant (B=-0.15, p=0.014 and B=1.042 and p=0.054, respectively). Conclusions The extent of myocardial scar and viability of LAD territory are identified as the important and independent parameters for the predictions of improvement in EF even after adjustment for demographics and baseline EF and following the standards of care medication.
No takes yet. Share an insight, caveat, or question.
Enein et al. (2020) conducted an observational in Ischemic Cardiomyopathy (n=178). Myocardial scar burden (Left Ventricular Scar Score) was evaluated on Change in follow-up left ventricular ejection fraction (LVEF) (B -3.038, 95% CI -5.9 to -0.2, p=0.038). Total myocardial scar score (B=-3.038) and left anterior descending artery territory viability independently predicted changes in follow-up left ventricular ejection fraction in patients with ischemic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: